Immune cells are required for cutaneous ulceration in a swine model of chancroid.
Cutaneous lesions of the human sexually transmitted genital ulcer disease chancroid are characterized by the presence of intraepidermal pustules, keratinocyte cytopathology, and epidermal and dermal erosion. These lesions are replete with neutrophils, macrophages, and CD4(+) T cells and contain very low numbers of cells of Haemophilus ducreyi, the bacterial agent of chancroid. We examined lesion formation by H. ducreyi in a pig model by using cyclophosphamide (CPA)-induced immune cell deficiency to distinguish between host and bacterial contributions to chancroid ulcer formation. Histologic presentation of H. ducreyi-induced lesions in CPA-treated pigs differed from ulcers that developed in immune-competent animals in that pustules did not form and surface epithelia remained intact. However, these lesions had significant suprabasal keratinocyte cytotoxicity. These results demonstrate that the host immune response was required for chancroid ulceration, while bacterial products were at least partially responsible for the keratinocyte cytopathology associated with chancroid lesions in the pig. The low numbers of H. ducreyi present in lesions in humans and immune-competent pigs have prevented localization of these organisms within skin. However, H. ducreyi organisms were readily visualized in lesion biopsies from infected CPA-treated pigs by immunoelectron microscopy. These bacteria were extracellular and associated with necrotic host cells in the epidermis and dermis. The relative abundance of H. ducreyi in inoculated CPA-treated pig skin suggests control of bacterial replication by host immune cells during natural human infection.
San Mateo
L R
LR
Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA.
Toffer
K L
KL
Orndorff
P E
PE
Kawula
T H
TH
D000818:Animals; D002602:Chancroid / Q000276:immunology* / Q000382:microbiology / Q000473:pathology*; D003520:Cyclophosphamide / Q000494:pharmacology; D004195:Disease Models, Animal; D006191:Haemophilus ducreyi / Q000276:immunology; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007962:Leukocytes / Q000166:cytology / Q000276:immunology; D012867:Skin / Q000382:microbiology / Q000473:pathology; D012883:Skin Ulcer / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D013552:Swine
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide